Beta Drugs Limited — Others, 13-01-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

MUFG Intime India Private Ltd. has confirmed compliance with the dematerialization process for Beta Drugs Limited for the quarter ending 31st December 2024. They report that securities received from depository participants were duly verified and confirmed for listing on the relevant stock exchanges. No demat or remat requests were processed during this period, indicating stability in the securities handling process. This update reflects operational efficiency, which may enhance investor confidence, supporting a positive outlook as the company maintains robust compliance standards.